Literature DB >> 1587788

A trisialoganglioside containing a sialyl alpha 2-6 N-acetylgalactosamine residue is a cholinergic-specific antigen, Chol-1 alpha.

S Ando1, Y Hirabayashi, K Kon, F Inagaki, S Tate, V P Whittaker.   

Abstract

Cholinergic-specific antigens termed the Chol-1 family have been suggested to be of a ganglioside nature by Richardson et al. (J. Neurochem. 38, 1605-1614, 1982). Two molecular species of polysialogangliosides among bovine brain gangliosides were found to react with anti-Chol-1 alpha antiserum. One of them, Chol-1 alpha-a, was isolated and characterized as a trisialoganglioside containing the gangliotetraose backbone in which 1 mol of sialic acid was attached to each of the reducing end galactose, N-acetylgalactosamine and internal galactose residues, respectively. The chemical structure of Chol-1 alpha-a was determined for the first time, being as follows: IV3NeuAc III6NeuAc II3NeuAc-GgOse4 Cer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587788     DOI: 10.1093/oxfordjournals.jbchem.a123751

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  21 in total

1.  Total synthesis of a cholinergic neuron-specific ganglioside GT1a alpha: a high affinity ligand for myelin-associated glycoprotein (MAG).

Authors:  H Ito; H Ishida; H Waki; S Ando; M Kiso
Journal:  Glycoconj J       Date:  1999-10       Impact factor: 2.916

Review 2.  Structures, biosynthesis, and functions of gangliosides--an overview.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga; Makoto Yanagisawa
Journal:  J Oleo Sci       Date:  2011       Impact factor: 1.601

3.  Structure of the main ganglioside from the brain of Xenopus laevis.

Authors:  Angela Maria Rizzo; Bruno Berra; Federica Rossi; Anna Guerra; Rosalba Gornati; Giovanni Bernardini; Takao Taki; Takeshi Kasama; Laura Mauri; Sandro Sonnino
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

Review 4.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 5.  Gangliosides in Nerve Cell Specification.

Authors:  Yutaka Itokazu; Jing Wang; Robert K Yu
Journal:  Prog Mol Biol Transl Sci       Date:  2018-01-17       Impact factor: 3.622

6.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

Review 7.  Cholinergic-specific glycoconjugates.

Authors:  V P Whittaker; S Kelić
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

8.  A novel ganglioside with a free amino group in bovine brain.

Authors:  K I Hidari; F Irie; M Suzuki; K Kon; S Ando; Y Hirabayashi
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  Synaptic function of cholinergic-specific Chol-1alpha ganglioside.

Authors:  Susumu Ando; Yasukazu Tanaka; Satoru Kobayashi; Fumiko Fukui; Machiko Iwamoto; Hatsue Waki; Tadashi Tai; Yoshio Hirabayashi
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

Review 10.  Gangliosides of the Vertebrate Nervous System.

Authors:  Ronald L Schnaar
Journal:  J Mol Biol       Date:  2016-05-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.